T cell, also known as T lymphocyte, is a form of leukocyte or white blood cell that plays a vital role in the immune system. T cells are among two basic types of lymphocytes, the other being B cells that define the specificity of the immune system to antigens or foreign substances in the body.
T cells’ functions change slightly throughout a person’s life. Naive T cells are essential for protecting against common infections or antigens throughout infancy. Long-term “reserves of memory T cells” are created during this phase, and they can be maintained throughout adulthood.
T cells’ roles change slightly during a person’s life. During this phase, long-term stores of memory T cells get formed, and they can be maintained until adulthood. Infancy, naive T cells are crucial for immunity against common infections or antigens.
T cell functionality declines as we age, depending on immune system dysregulation and related diseases. When fewer novel antigens are encountered in maturity, they primarily operate to maintain immunoregulation and homeostasis of recurrent or chronically encountered antigens. During this time in life, there is some emphasis on tumour surveillance.
“T cell exhaustion” plays a significant role in tumour protection during cancer. According to the study, some cancer-associated cells and tumour cells can actively cause T cell fatigue at the tumour site. As demonstrated in leukaemia, cell fatigue can also play a significant role in cancer relapses. Some researchers have suggested that the activation of “inhibitory receptors PD-1 and TIM-3 by T cells” can be used to predict leukaemia relapse. [83] Many investigations and clinical trials in cancer therapy have focused on immunotherapy blockers, with some of these authorised as viable medications in clinical use. These medical techniques target inhibitory receptors, essential in T cell fatigue, and inhibiting them can restore these changes.